SYNERLAB GROUP’s Post

Finally, I am presenting! It's Monday, November 4, at 1pm. Bring us your innovative high- concentration, high-dose, high- volume antibody, we have Huonslab proprietary SC drug delivery platform based on the recombinant human hyaluronidase PH20, HyDIFFUZE. Give your antibody a chance to become a blockbuster one day through co-formulation with HyDIFFUZE. HyDIFFUZE accompanies your antibody in a single vial throughout the extremely tight human SC space by breaking down hyaluronan in the ECM, and facilitates to traverse lymphatics or capillaries more rapidly and easily before entering systemic circulation. HyDIFFUZE: a transiently active and locally acting permeation enhancer, a validated, affordable and accessible SC antibody drug delivery platform to the industry. The scale has already been tipped towards SC antibodies in co-formulation with rHuPH20. Webinar, Scientifically sound documents FAQ27, VDR ready to be delivered. MCB and WCB fully characterized by a renowned UK company & the full US standard analyses in 17 different items. To start small, PFS, a pre-formulation service available: your blockbuster candidate antibody+HyDIFFUZE for 3 months period. Huonslab and other Huons affiliates put together decades hands on experience in EPO, Hyaluronan and botulinum toxins for the development of HyDIFFUZE since 2019 which is a validated HCAF, HD/HV antibody Sub-Q delivery platform. UHCAF with HyDIFFUZE in a potential auto injector device delivery upto 40mL.

Curious about how GenAI is transforming the discovery of biostimulants and biocontrol agents? Don’t miss agrematch’s CEO, Eyal Ben-Chanoch, as he presents groundbreaking insights at the World Biostimulant Congress in Miami on Nov. 15, 2024. Join us to explore the future of agricultural innovation! https://lnkd.in/dDF7VGZw #Biostimulants #Biocontrol #GenAI #AI4AI

Come meet us at booth 47 to discuss your bioprocess development and manufacturing needs!

Wow, can you believe it's already been a whole week? I swear, time flies! Last week, I found myself in Barcelona with Dave Mead for BioEurope Spring. Picture this: a gorgeous city is the backdrop for a group of people eager to mix business with science. And let's not forget the added thrill of knowing about Barcelona's false sense of security (right, Dave?). Our Welcome Reception was at the Museu Marítim de Barcelona – talk about a gorgeous venue, as you can clearly see in the first photo. Shoutout to some familiar faces for making me feel like I was confortable amongst colleagues (Mandeep Sehmi, Ana Rita Ricardo, Philip Cunnah, and Jasmin Bannister). The wine didn't hurt either. Now, onto the main event: BioEurope Spring at the CCIB, where over 1800 companies and 3400 delegates gathered to talk shop. These were long days – starting at 8.30am and wrapping up after 6.30pm. This is if your networking doesn't continue into dinner time - major kudos to Lonza for keeping our bellies full and our networking game strong! Amidst the hustle and bustle, I managed to carve out some quality downtime. Finally putting faces to names at the BioPartner UK stand with Lin Bateson and chilling at the One Nucleus booth. And let's not forget my little slice of Portuguese quality time at the Rodon Biologics stand – obrigado e ate breve! Meeting fascinating people with even more fascinating scientific endeavors was the cherry on top. Not only did we get to flex our scientific team's expertise, but we also got to dream up new ways to use Isogenica Limited's VHHs - yep, we're Building Dreams (trademark pending)! Three marathon days later, and I'm filled with memories, sharpened skills, promising leads, and many new contacts. Now comes the next stage: following up on those potential partnerships (and maybe making the most of our CRM while we're at it). #BioEurope #BusinessDevelopment #science #Barcelona

Together with Hanaa SAFYA, PhD, we are eager to connect and discuss with you how our latest advanced technologies that might support your Diagnostics R&D goals.   Our ♨️ topics this year include   ➡️The COLPLEX technology, a multiparametric point of care diagnostics. This alternative to the long-established streptavidin/biotin capture system with the unique advantage of multiplexing capacity. We have successfully demonstrated - through a grant from the BMGF (see Multiway https://lnkd.in/dUgKN_UX ) - that COLPLEX can outperform current limitations of multiplexing lateral flow assay, notably in sensitivity. The COLPLEX technology represents a widely applicable and cost-effective advance in immunoassay technology for new diagnostic applications associated with medical needs requiring high-performance multiplex rapid tests   ➡️A blood based-transcriptomic signature capable of differentiating active tuberculosis patients from healthy and asymptomatic latently infected individuals and allowing to monitor tuberculosis treatment and predict therapy outcome. This signature is ready to be out-licensed and developed on a commercial PCR platform (see Isit-tb https://lnkd.in/dJnpPzMq )   ➡️Advanced imaging combined with machine learning-based approaches that permit identification and characterization of micro-organisms and their susceptibility to antibiotics from direct clinical samples thus bypassing culture-based methods and reducing time-to-results (see CODIRA https://lnkd.in/dZkreX2U )   ➡️And even more if you are curious, one step beyond (see Diagnostics & Companion Diagnostics https://lnkd.in/dyZUFZ6f )!   🔔 Interested or simply curious? Don’t hesitate to meet us or reach out to Hanaa SAFYA, PhD or me to schedule a meeting. We’re excited to explore how we can partner to bring impactful diagnostic solutions to life!

Tune in and hear the latest on Biostimulants. #syngentabiologicals #centralvalleyag #centralcoastag

Really looking forward to this discussion about the type of ESG issues clients are facing, and how they are dealing with them - including during contract negotiation and on live construction projects. Only a few more days left of Early Bird pricing, so don't miss out!

MEDICA - Leading International Trade Fair Booth 13D88 : 27 years ago, I presented a breakthrough innovation Occigerm, a medical waste disinfector with an efficiency of 13 Log while the competition was at 5 Log! Today we present, with Romain Deixonne our CMO who will soon become our CEO (thank you so much Romain!), a connected insole without battery, Warnfeet, equipped with 150 pressure measurement points that warn on smartphone of the risks of diabetic foot ulcers for the 50 million people amputated each year for a cost 20 times lower than the competition! French Tech Perpignan La French Tech San Diego Bpifrance EU|BIC Plein Sud Entreprises IMPACT - Perpignan Méditerranée Métropole Pôle Entreprises Perpignan Sud A2peps CAP SUD 66 UPVD IN CUBE Caisse d'Epargne Languedoc-Roussillon BNP Paribas Elkem ASA BASF Biesterfeld Group Arkema Electronics CAP'TRONIC ISPO IMPULSE PARTNERS - A FAST LANE FOR INNOVATION SATT AxLR SFINE SFIA - Sports & Fitness Industry Association Maison de l'Occitanie à New York La Région Occitanie / Pyrénées-Méditerranée OVH Cloud PRO BTP Groupe Initiative Pays Catalan POLYMERIS Eurobiomed Prix Alfred Sauvy

Looking forward to speak about complexity, adaptation and how we can do human better at the Bioss2024 conference.

Changing chemistry is fundamental. Changing fuel is immediately beneficial for the planet. Catching on to the wave here at Biofuels International Conference and Expo in Brussels with CEO Tim Cesarek for Synata Bio who make ethanol from CO2 and hydrogen by means of microorganisms, for fuels and chemicals. #greenchemistry #circularity #sustainability #saf #greenhydrogen #decarbonization